全文获取类型
收费全文 | 98377篇 |
免费 | 8121篇 |
国内免费 | 3924篇 |
专业分类
耳鼻咽喉 | 1011篇 |
儿科学 | 2426篇 |
妇产科学 | 1798篇 |
基础医学 | 10731篇 |
口腔科学 | 2033篇 |
临床医学 | 8713篇 |
内科学 | 12812篇 |
皮肤病学 | 1476篇 |
神经病学 | 3985篇 |
特种医学 | 4260篇 |
外国民族医学 | 60篇 |
外科学 | 12972篇 |
综合类 | 15938篇 |
现状与发展 | 21篇 |
一般理论 | 1篇 |
预防医学 | 3514篇 |
眼科学 | 1192篇 |
药学 | 8016篇 |
58篇 | |
中国医学 | 3244篇 |
肿瘤学 | 16161篇 |
出版年
2024年 | 221篇 |
2023年 | 1483篇 |
2022年 | 3778篇 |
2021年 | 4585篇 |
2020年 | 3611篇 |
2019年 | 3536篇 |
2018年 | 3500篇 |
2017年 | 3360篇 |
2016年 | 3376篇 |
2015年 | 3748篇 |
2014年 | 6118篇 |
2013年 | 6268篇 |
2012年 | 5668篇 |
2011年 | 6225篇 |
2010年 | 5149篇 |
2009年 | 4985篇 |
2008年 | 4935篇 |
2007年 | 5080篇 |
2006年 | 4393篇 |
2005年 | 3960篇 |
2004年 | 3430篇 |
2003年 | 2930篇 |
2002年 | 2497篇 |
2001年 | 2241篇 |
2000年 | 1902篇 |
1999年 | 1738篇 |
1998年 | 1608篇 |
1997年 | 1487篇 |
1996年 | 1243篇 |
1995年 | 1090篇 |
1994年 | 946篇 |
1993年 | 711篇 |
1992年 | 601篇 |
1991年 | 516篇 |
1990年 | 408篇 |
1989年 | 363篇 |
1988年 | 372篇 |
1987年 | 278篇 |
1986年 | 238篇 |
1985年 | 317篇 |
1984年 | 286篇 |
1983年 | 169篇 |
1982年 | 233篇 |
1981年 | 192篇 |
1980年 | 157篇 |
1979年 | 154篇 |
1978年 | 104篇 |
1977年 | 76篇 |
1976年 | 59篇 |
1975年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
62.
63.
64.
65.
66.
Hypoxiaisadirectfactorcausinghypoxicpul monaryhypertension (HPH) .hypoxiainduciblefac tor 1α (HIF 1α)isfoundtobethemostcrucialfactorsofarwhichmediatesthecellularresponsetohypoxi a[1] .OurpreviousstudyrevealedthatoverexpressionofHIF 1andendothelin 1(ET 1… 相似文献
67.
Darren S Parsons David A Reaveley Darrell V Pavitt Madhukar Misra Edwina A Brown 《Nephrology, dialysis, transplantation》2003,18(9):1848-1853
BACKGROUND: Studies have reported an increase in median Lipoprotein (Lp) (a) in patients with high molecular weight (HMW) apolipoprotein (apo) (a) isoforms and renal impairment. Some studies identify Lp (a) levels as a risk factor for vascular disease in renal failure whilst others have demonstrated an association with apo (a) isoform type and vascular disease. METHODS: A total of 239 patients at end-stage renal failure (ESRF) were studied prior to the initiation of dialysis. Blood was taken for Lp (a) levels and apo (a) isoforms. Clinical vascular disease (CVD) was assessed on the basis of clinical history and Rose questionnaire. The control group for Lp (a) levels consisted of 228 healthy volunteers. RESULTS: Despite a higher median Lp (a) level in those with HMW isoforms, 30% of patients had Lp (a) levels <10 mg/dl. Overall, 49% patients were identified as having CVD. Diabetes, smoking history and Lp (a) levels were significantly associated with CVD in logistic regression analysis, although when patients with low molecular weight (LMW) and HMW isoforms were analysed separately, Lp (a) levels were not significantly associated with CVD in those with LMW isoforms. The rates of CVD in those with HMW isoform and low Lp (a) levels were significantly lower than those with HMW isoforms and elevated Lp (a) levels, 34 vs 57% (P < 0.01). CONCLUSIONS: Although median Lp (a) levels in those patients at ESRF with HMW isoforms are higher than controls, in a third of such patients Lp (a) levels remain relatively low. These patients have lower rates of CVD than those with high levels of Lp (a). 相似文献
68.
Hidekazu Mukai Hiroshi Yoshinaga Akihiko Watanabe Hitoshi Fujiwara Tsuyoshi Fujita 《Digestive endoscopy》2004,16(Z1):S58-S61
After removal of intraductal stones, a 10‐Fr or 7‐Fr pancreatic stent was placed in 16 patients with upstream ductal dilation proximal to a stricture of the main pancreatic duct. Stents were removed after a mean duration of 52.5 days. Nine patients underwent repeated stenting. About one year after removal of the initial stent, when the remaining upstream ductal dilation was found on follow‐up pancreatograms, the next stent was replaced. Repeated stenting improved outflow of pancreatic juice more effectively than one‐time stenting. Correlation between long‐term pain relief without recurrence of intraductal stones and reduction of duct diameter was also shown. Stent occlusion was observed in 14 of 30 stents. Stent occlusion was frequently associated with recurrence of pancreatitis and intraductal stones, and was also associated with morphologic changes in the pancreatic ductal system. Although there were no significant differences between stent patency of the initial stents and that of the next stents, stent patency of 10‐Fr stents was superior to that of 7‐Fr stents. 10‐Fr stents should be removed within 8 weeks and 7‐Fr stents should be removed within 4 weeks for the prevention of stent occlusion. Repeated stenting with short‐term stenting is therefore considered a safe and effective protocol of endoscopic pancreatic stenting. 相似文献
69.
70.